News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Growth Equity Opportunities Fund, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/13/2014 |
SC 13D/A
| Growth Equity Opportunities Fund, LLC reports a 10.6% stake in Sunesis Pharmaceuticals, Inc. |
| 01/31/2014 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/13/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/13/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/21/2011 |
SC 13D/A
| Growth Equity Opportunities Fund, LLC has filed a Schedule 13D for ARYx Therapeutics, Inc. |
| 02/07/2011 |
SC 13G/A
| Growth Equity Opportunities Fund, LLC reports a 6% stake in Orexigen Therapeutics, Inc. |
| 07/09/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 02/05/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/15/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 11/17/2009 |
SC 13D
| Growth Equity Opportunities Fund, LLC reports a 36.7% stake in Sunesis Pharmaceuticals, Inc. |
| 09/17/2009 |
SC 13D
| Growth Equity Opportunities Fund, LLC reports a 8.2% stake in NeuroMetrix, Inc. |
| 04/13/2009 |
SC 13D
| Form SC 13D -- General statement of acquisition of beneficial ownership |
|
|